Ads
related to: monoclonal antibody
Search results
MacroGenics to Participate in Upcoming Investor Conferences
Morningstar· 4 days agoROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal ...
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 4 days agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...
Pipeline Moves: Phase III completion for Corcept’s relaorilant
Clinical Trials Arena via Yahoo Finance· 4 days agoAlso, Lyvgen’s monoclonal antibody (mAb) dalnicastobart has seen its transition prospects increase...
GSK to divest remaining 4.2% stake in Haleon
Pharmaceutical Technology via Yahoo Finance· 7 hours agoThe agreement comprises an upfront payment of $1bn and $400m in regulatory milestone payments. Through the deal, GSK will gain access to AIO-001, a...
Sanofi to Spend $1.08 Billion to Boost Drug Production in France
Morningstar· 4 days agoSanofi will spend more than 1 billion euros ($1.08 billion) on ramping up production capability in France. The French pharmaceutical company said Monday that the bulk of the investment will ...
Adagene Inc. (NASDAQ:ADAG) Short Interest Up 6.3% in April
ETF DAILY NEWS· 11 hours agoAdagene Inc. (NASDAQ:ADAG – Get Free Report) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 15,100 shares, an increase ...
Uniquity Bio launches to focus on immunology and inflammation
Pharmaceutical Technology via Yahoo Finance· 1 day agoA monoclonal antibody, solrikitug targets thymic stromal lymphopoietin. It will treat critical...
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 7 days agoThe company’s trial was evaluating the cancer-drug Opdivo and concurrent chemoradiotherapy, followed...
Sanofi boosts French biomanufacturing with €1 billion investment
Investing.com· 4 days agoSanofi (EPA: SASY ) (NASDAQ: SNY ), a global biopharmaceutical company, announced today a...
Immunovant, Inc. (NASDAQ:IMVT) Short Interest Update
ETF DAILY NEWS· 12 hours agoImmunovant, Inc. (NASDAQ:IMVT – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 8,960,000 shares, ...